A national platform for diagnostic laboratories to share genetic evidence and build consistent interpretations of that information is paving the way for more accurate diagnosis of patient conditions.
Nov 4, 2022
0
3
Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in Molecular ...
Nov 2, 2022
0
73
In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute (DHVI) has demonstrated wide protection against SARS-CoV-2 viruses and variants, including omicron BA.5.
Oct 28, 2022
0
128
The Association for Molecular Pathology (AMP), a global, molecular diagnostic professional society, today published consensus recommendations for the use of in silico approaches for validating Next-Generation Sequencing (NGS) ...
Oct 18, 2022
0
37
Scientists on Earth use high-energy protons to create isotopes to detect and treat cancer. In space, however, these same high-energy protons can pose a risk to spacecraft and the health of the astronauts traveling in them. ...
Oct 14, 2022
0
4
The COVID-19 epidemic continues to ravage the world. Various influencing factors in SARS-CoV-2 nucleic acid detection (NAT) and the significance of quantitative and qualitative detection capabilities deserve to be discussed, ...
Oct 10, 2022
0
17
Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not caused by impaired immune responses.
Oct 6, 2022
0
34
A single dose of healthy immune cells sped the recovery of muscle function in older mice following two weeks of physical inactivity, according to University of Utah Health scientists. They say the finding could eventually ...
Oct 4, 2022
0
11
Nigeria's Oligo synthesizer laboratory, the first in West Africa, could be a game changer in tackling emerging and re-emerging diseases in the region if harnessed to its full potential, laboratory scientists have said.
Sep 27, 2022
0
7
It may soon be possible to identify Group 4 medulloblastomas—the most common malignant brain tumor in children—from more aggressive Group 3 tumors. Research based on a little-explored part of RNA, which creates proteins, ...
Sep 21, 2022
0
3
